Form 8-K - Current report:
SEC Accession No. 0001641172-25-013632
Filing Date
2025-06-04
Accepted
2025-06-04 16:30:40
Documents
12
Period of Report
2025-05-29
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 48092
  Complete submission text file 0001641172-25-013632.txt   215872

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nrxs-20250529.xsd EX-101.SCH 3014
3 XBRL LABEL FILE nrxs-20250529_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE nrxs-20250529_pre.xml EX-101.PRE 22358
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3790
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

EIN.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41775 | Film No.: 251023557
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)